Cite
Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
MLA
Lai, I.Li, et al. “Survival Analysis of Local Excision vs Total Mesorectal Excision for Middle and Low Rectal Cancer in PT1/PT2 Stage and Intermediate Pathological Risk.” World Journal of Surgical Oncology, vol. 17, no. 1, Dec. 2019, p. 212. EBSCOhost, https://doi.org/10.1186/s12957-019-1763-9.
APA
Lai, I.-L., You, J.-F., Chern, Y.-J., Tsai, W.-S., Chiang, J.-M., Hsieh, P.-S., Hung, H.-Y., Yeh, C.-Y., Chiang, S.-F., Lai, C.-C., Tang, R.-P., Chen, J.-S., & Hsu, Y.-J. (2019). Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk. World Journal of Surgical Oncology, 17(1), 212. https://doi.org/10.1186/s12957-019-1763-9
Chicago
Lai, I-Li, Jeng-Fu You, Yih-Jong Chern, Wen-Sy Tsai, Jy-Ming Chiang, Pao-Shiu Hsieh, Hsin-Yuan Hung, et al. 2019. “Survival Analysis of Local Excision vs Total Mesorectal Excision for Middle and Low Rectal Cancer in PT1/PT2 Stage and Intermediate Pathological Risk.” World Journal of Surgical Oncology 17 (1): 212. doi:10.1186/s12957-019-1763-9.